Search results
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State...
Digital Journal· 2 days agoSTONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced ...
MDs' One-Word Summary of Long COVID Progress: 'Frustration'
Medscape· 4 days agoStuart Malcolm, MD, a primary care physician who practices in Oregon and northern California,...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Digital Journal· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older, including an ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Morningstar· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older, including an ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older, including an enhanced influenza vaccine in adults 65 years and...